E C Keystone, M C Genovese, L Klareskog, *et al*. Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. [*Ann Rheum Dis* 2009;**68**:789--796](http://ard.bmj.com/content/68/6/789.full). Due to a programming error pertaining to CRP units used in the DAS28-CRP calculations resulted in data errors. The DAS28-CRP values were calculated with CRP in units of mg/dL instead of mg/L and therefore the DAS values in Table 1 are incorrect. Please note, the conclusions from the study remain unchanged.

###### 

The DAS values in Table 1 have been published as follows:

                    Group 1                  Group 2                  Group 3                  Group 4                  Groups 3 and 4 Combined
  ----------------- ------------------------ ------------------------ ------------------------ ------------------------ -------------------------
  DAS28 using CRP   4.860 (4.194 to 5.480)   4.803 (4.151 to 5.558)   5.100 (4.060 to 5.651)   4.902 (4.320 to 5.521)   4.931 (4.174 to 5.598)

###### 

The correct DAS values in Table 1 should be published as follows:

                    Group 1                  Group 2                  Group 3                  Group 4                  Groups 3 and 4 Combined
  ----------------- ------------------------ ------------------------ ------------------------ ------------------------ -------------------------
  DAS28 using CRP   5.458 (4.672 to 6.093)   5.364 (4.683 to 6.236)   5.766 (4.628 to 6.322)   5.393 (4.748 to 6.172)   5.513 (4.721 to 6.271)
